Novo Holdings, the controlling shareholder of Novo Nordisk A/S, is topping up an investment in a Danish company specialized in superconductor technology, as part of an effort to accelerate new energy resources in Europe.
Kasim Kutay, chief executive officer of Novo Holdings A/S, following a Bloomberg Television interview in London, UK, on Wednesday, April 2, 2025. 'We're in unchartered waters because tariffs have not been applicable to pharmaceutical products for decades,' Kutay said.
Anmelden
